DR. JAMES HSIEH, MD
Osteopathic Medicine in Saint Louis, MO

License number
Missouri 2017009623
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
4921 Fl Siteman Cancer Ctr, Saint Louis, MO 63110
Phone
(314) 747-1171
(314) 362-3192 (Fax)

Personal information

See more information about JAMES HSIEH at radaris.com
Name
Address
Phone
James Hsieh
5583 Waterman Ave, Saint Louis, MO 63112

Organization information

See more information about JAMES HSIEH at bizstanding.com

James Hsieh MD,PHD

4921 Parkview Pl, Saint Louis, MO 63110

Industry:
Internist
Phone:
(314) 747-9270 (Phone)
James Jehng-Dauh Hsieh

Professional information

James Hsieh Photo 1

Dr. James Hsieh, New York NY - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Address:
1275 York Ave, New York 10065
(800) 525-2225 (Phone)
Siteman Cancer Center
4921 Parkview Pl, Saint Louis 63110
(314) 747-1171 (Phone)
Certifications:
Internal Medicine, 2000, Medical Oncology, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1275 York Ave, New York 10065
Siteman Cancer Center
4921 Parkview Pl, Saint Louis 63110
Barnes Jewish Hospital
1 Barnes Jewish Hospital Plz, Saint Louis 63110
Education:
Medical School
Taipei Medical College
Graduated: 1990
Barnes-Jewish Hospital
Dana Farber Canc Inst


James Hsieh Photo 2

Associate Professor At Washington University School Of Medicine

Position:
Associate Professor at Washington University School of Medicine
Location:
Greater St. Louis Area
Industry:
Research
Work:
Washington University School of Medicine - Associate Professor


James Hsieh Photo 3

Taspase1 And Methods Of Use

US Patent:
2006006, Mar 30, 2006
Filed:
Oct 26, 2004
Appl. No.:
10/974127
Inventors:
James Hsieh - Ladue MO, US
Stanley Korsmeyer - Weston MA, US
Susan Korsmeyer - Weston MA, US
Emily Cheng - Ladue, MO
International Classification:
C12N 9/64, C07H 21/04, C12P 21/06
US Classification:
435226000, 435069100, 435320100, 435325000, 536023200
Abstract:
A novel protease, Taspase1, is described. Taspase1 is involved in the cleavage of the MLL protein, which is required for proper HOX gene regulation. Diagnostic methods utilizing Taspase1 are provided, as well as inhibitors of Taspase1. Methods of using the inhibitors of Taspase1 are also described. For example an inhibitor of Taspase1 can be used to treat a cancer, e.g., leukemia, in a subject.


James Hsieh Photo 4

Taspase1 And Methods Of Use

US Patent:
2008017, Jul 24, 2008
Filed:
Sep 6, 2007
Appl. No.:
11/851301
Inventors:
James J.D. Hsieh - Ladue MO, US
Stanley J. Korsmeyer - Weston MA, US
Susan Korsmeyer - Weston MA, US
International Classification:
C07K 7/06, C07K 5/10
US Classification:
530329, 530330
Abstract:
A novel protease, Taspase1, is described. Taspase1 is involved in the cleavage of the myeloid/lymphoid or mixed-lineage leukemia (i.e., MLL) protein, which is required for proper HOX gene regulation. Diagnostic methods utilizing Taspase1 are provided, as well as inhibitors of Taspase1. Methods of using the inhibitors of Taspase1 are also described. For example an inhibitor of Taspase1 can be used to treat a cancer, e.g., leukemia, in a subject.